Gliptins are inhibitors of the dipeptidyl peptidase-4 (DPP4) enzyme and have demonstrated a vasoprotective and vasoregenerative impact after endothelial injury and during early atherosclerosis. Here, DPP4 is linked to atherosclerosis.